Rituximab for the treatment of rheumatoid arthritis
Bagust A, Boland A, Hockenhull J, Fleeman N, Greenhalgh J, Dundar Y, Proudlove C, Kennedy T, Moots R, Williamson P, Dickson R
Record ID 32013000707
English
Authors' recommendations:
At the time of writing the guidance issued by NICE (August 2007) states that:
Rituximab in combination with methotrexate is recommended as an option for the treatment of adults with severe active rheumatoid arthritis who have had an inadequate response to or intolerance of other disease-modifying antirheumatic drugs (DMARDs), including treatment with at least one tumour necrosis factor-α (TNF-α) inhibitor therapy.
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.journalslibrary.nihr.ac.uk/hta/hta13Suppl2-04/#/abstract
URL for additional information:
http://www.journalslibrary.nihr.ac.uk/hta/volume-13/suppl-2-article-4
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Antibodies, Monoclonal, Murine-Derived
- Quality-Adjusted Life Years
- Randomized Controlled Trials as Topic
- Rituximab
- Antibodies, Monoclonal
- Antirheumatic Agents
- Arthritis, Rheumatoid
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.